Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darunavir efficacy and safety study in virologically suppressed adults with HIV infection
PACTR201409000836146Not yet recruiting
- Sponsor
- University of Liverpool
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of darunavir and ritonavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by University of Liverpool. Primary endpoint: HIV-1 RNA viral load suppression <400 copies/mL. Planned start May 2014; status: not yet recruiting.
02
Drugs
darunavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR201409000836146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201409000836146.